Rigel Pharmaceuticals Depreciation & Amortization 2011-2026 | RIGL

Annual Depreciation & Amortization Rigel Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
2.23 M	1.24 M	998 K	1.16 M	706 K	683 K	594 K	465 K	941 K	1.44 M	2.36 M	2.59 M	2.43 M	1.96 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.59 M	465 K	1.41 M

Quarterly Depreciation & Amortization Rigel Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
600 K	600 K	604 K	600 K	600 K	400 K	300 K	300 K	357 K	-	714 K	-	237 K	-	758 K	-	239 K	-	500 K	335 K	171 K	-	503 K	337 K	164 K	-	431 K	272 K	113 K	-	352 K	240 K	126 K	-	798 K	584 K	324 K	-	1.1 M	814 K	435 K	-	1.85 M	1.28 M	655 K	-	1.94 M	1.3 M	669 K	-	1.8 M	1.16 M	552 K	-	1.43 M	923 K	447 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.94 M	113 K	649 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Apellis Pharmaceuticals APLS	1.56 M	$ 20.41	-1.4 %	$ 2.57 B	USA
Aptorum Group Limited APM	1.13 M	$ 0.79	-6.51 %	$ 4.31 M	China
Axsome Therapeutics AXSM	503 K	$ 165.07	-0.79 %	$ 8.21 B	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
AbCellera Biologics ABCL	18.4 M	$ 3.76	-1.7 %	$ 1.12 B	Canada
Corvus Pharmaceuticals CRVS	151 K	$ 18.11	1.23 %	$ 870 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Capricor Therapeutics CAPR	1.07 M	$ 26.36	-1.82 %	$ 706 M	USA
Certara CERT	75.2 M	$ 7.24	2.62 %	$ 1.16 B	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
Codexis CDXS	4.95 M	$ 1.01	-0.98 %	$ 74.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Catalyst Pharmaceuticals CPRX	375 K	$ 23.77	-0.46 %	$ 2.91 B	USA
Agenus AGEN	13.6 M	$ 3.27	-2.09 %	$ 1.17 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Agios Pharmaceuticals AGIO	5.2 M	$ 28.85	-1.2 %	$ 1.67 B	USA
Champions Oncology CSBR	1.6 M	$ 5.98	-1.48 %	$ 81.7 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Alector ALEC	5.72 M	$ 2.13	-3.39 %	$ 219 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aileron Therapeutics ALRN	63 K	-	10.36 %	$ 9.8 M	USA
Altimmune ALT	238 K	$ 4.22	1.32 %	$ 300 M	USA
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Amarin Corporation plc AMRN	3.02 M	$ 14.3	2.66 %	$ 5.93 B	Irlanda
AbbVie ABBV	762 M	$ 233.44	-0.33 %	$ 413 B	USA